End‐of‐Life Cost Trajectories in Cancer Patients Treated by Medicare versus the Veterans Health Administration.

MLA

Gidwani, Risha, et al. “End‐of‐Life Cost Trajectories in Cancer Patients Treated by Medicare versus the Veterans Health Administration.” Journal of the American Geriatrics Society, vol. 69, no. 4, Apr. 2021, pp. 916–23. EBSCOhost, https://doi.org/10.1111/jgs.16941.

APA

Gidwani, R., Asch, S. M., Needleman, J., Faricy, A. K., Boothroyd, D. B., Illarmo, S., Lorenz, K. A., Patel, M. I., Hsin, G., Ramchandran, K., & Wagner, T. H. (2021). End‐of‐Life Cost Trajectories in Cancer Patients Treated by Medicare versus the Veterans Health Administration. Journal of the American Geriatrics Society, 69(4), 916–923. https://doi.org/10.1111/jgs.16941

Chicago

Gidwani, Risha, Steven M. Asch, Jack Needleman, Anderson, Katherine Faricy, Derek B. Boothroyd, Samantha Illarmo, Karl A. Lorenz, et al. 2021. “End‐of‐Life Cost Trajectories in Cancer Patients Treated by Medicare versus the Veterans Health Administration.” Journal of the American Geriatrics Society 69 (4): 916–23. doi:10.1111/jgs.16941.